No Data
Syndax Pharmaceuticals (SNDX) Gets a Buy From Stifel Nicolaus
Express News | Citigroup Maintains Buy on Syndax Pharmaceuticals, Lowers Price Target to $30
Syndax Pharmaceuticals Is Maintained at Buy by Stifel
Syndax Pharmaceuticals Is Maintained at Buy by Stifel
Express News | Syndax Pharmaceuticals Inc : Stifel Raises Target Price to $40 From $39
Syndax Announces Participation at the Bank of America Securities 2024 Health Care Conference
Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today...
Express News | HC Wainwright & Co. Reiterates Buy on Syndax Pharmaceuticals, Maintains $41 Price Target